These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 19154957

  • 1. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ, Rawal B, Khan NA, Yeramaneni S, Goldenberg N, Wang P.
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [Abstract] [Full Text] [Related]

  • 2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [Abstract] [Full Text] [Related]

  • 5. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
    Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH.
    Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH, Paramsothy P.
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract] [Full Text] [Related]

  • 8. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH.
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [Abstract] [Full Text] [Related]

  • 9. Update on statins.
    Mason P.
    J Vasc Nurs; 2004 Jun; 22(2):49-50. PubMed ID: 15179417
    [No Abstract] [Full Text] [Related]

  • 10. Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.
    Hirsch M, O'Donnell JC, Jones P.
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):18-28. PubMed ID: 15703502
    [Abstract] [Full Text] [Related]

  • 11. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S, Kaczmarek I, Delgado O, Schmöckel M, Reichart B, Meiser B.
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM, Penning-van Beest FJ, Plat AW, Meerding WJ, Webb K, Sturkenboom MC, Herings RM.
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [Abstract] [Full Text] [Related]

  • 13. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P.
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [Abstract] [Full Text] [Related]

  • 14. Achieving lipid goals in real life: the Dutch DISCOVERY study.
    Bots AF, Kastelein JJ, Discovery Netherlands Investigators.
    Int J Clin Pract; 2005 Dec; 59(12):1387-94. PubMed ID: 16351669
    [Abstract] [Full Text] [Related]

  • 15. The risk for significant creatine kinase elevation with statins.
    Stolcpart RS, Olson KL, Delate T, Rasmussen J, Rehring TF, Merenich JA.
    Am J Cardiovasc Drugs; 2010 Dec; 10(3):187-92. PubMed ID: 20524720
    [Abstract] [Full Text] [Related]

  • 16. Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
    Wlodarczyk J, Sullivan D, Smith M.
    Am J Cardiol; 2008 Dec 15; 102(12):1654-62. PubMed ID: 19064019
    [Abstract] [Full Text] [Related]

  • 17. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A, Jovell AJ, García-Altés A, García-Closas R, Serra-Majem L.
    Clin Ther; 1999 Nov 15; 21(11):1924-36. PubMed ID: 10890264
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G, Nusca A, Chello M, Pasceri V, D'Ambrosio A, Vetrovec GW, Di Sciascio G.
    Am J Cardiol; 2008 Feb 01; 101(3):279-85. PubMed ID: 18237585
    [Abstract] [Full Text] [Related]

  • 19. [Pharmaco-economic optimization of cholesterol-lowering treatment with statins].
    Ruiz García A, Gordillo López FJ, Arranz Martínez E, Hermosa Hernán JC.
    Med Clin (Barc); 2011 Jun 25; 137(3):119-25. PubMed ID: 21074814
    [Abstract] [Full Text] [Related]

  • 20. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep 25; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.